Analyst firms · Morgan Stanley · TMCI
Morgan Stanley TMCI price target and rating history
Treace Medical Concepts Inc. (TMCI) · Health Care
Morgan Stanley rates Treace Medical Concepts Inc. (TMCI) Equal-Weight with a $5.50 price target, as of its latest action on May 8, 2024. It has published 3 rating actions on TMCI since January 2022, including 1 upgrade and 1 downgrade.
- Current rating
- Equal-Weight
- Price target
- $5.50
- Median target, all firms
- Too few
- Actions on TMCI
- 3
Morgan Stanley price target on TMCI
Every Morgan Stanley rating on TMCI
- May 8, 2024
- Mar 4, 2022
- Jan 7, 2022
Questions about Morgan Stanley and TMCI
- What is Morgan Stanley's price target for TMCI?
- Morgan Stanley's latest stated price target for Treace Medical Concepts Inc. (TMCI) is $5.50, from its action on May 8, 2024.
- What is Morgan Stanley's rating on TMCI?
- Morgan Stanley rates TMCI Equal-Weight, a neutral rating, as of May 8, 2024.
- When did Morgan Stanley last change its view on TMCI?
- On May 8, 2024, Morgan Stanley downgrades to Equal-Weight from Overweight, price target $15 to $5.50.
More TMCI rating histories
All Morgan Stanley ratingsTMCI news and filingsEvery analyst firm
From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.